Pandion Therapeutics Inc. (PAND) NASDAQ/NGS (GLOBAL SELECT MARKET)

$60.05 - (-)

Market Cap: -

As of 03/31/21 12:00 AM EDT. Market closed.

(PAND)

Pandion Therapeutics Inc. (PAND)
NASDAQ/NGS (GLOBAL SELECT MARKET)

$60.05
- (-)

Market Cap: -

As of 03/31/21 12:00 AM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
PRICE CHART FOR PANDION THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$59.99
Previous Close
$60.05
Days Range
$59.95 - $60.05
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
29,515,583
Open
$59.99
Previous Close
$60.05
Days Range
$59.95 - $60.05
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
29,515,583
FINANCIAL STATEMENTS FOR PANDION THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PANDION THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Viney Joanne L.See RemarksApr 01, 2021 Option Exercise$60.001,20072,0000Apr 01, 2021, 07:59 PM
Viney Joanne L.See RemarksApr 01, 2021 Option Exercise$60.00503,25430,195,2400Apr 01, 2021, 07:59 PM
Goyal VikasSee RemarksApr 01, 2021 Option Exercise$60.0087,7645,265,8400Apr 01, 2021, 07:58 PM
Crane Alan LDirectorApr 01, 2021 Option Exercise$60.0084,1585,049,4800Apr 01, 2021, 07:57 PM
Crane Alan LDirectorApr 01, 2021 Option Exercise$60.003,201,422192,085,3200Apr 01, 2021, 07:57 PM
Crane Alan LDirectorApr 01, 2021 Option Exercise$60.00336,31420,178,8400Apr 01, 2021, 07:57 PM
Freedman Edward D.Chief Operating OfficerApr 01, 2021 Option Exercise$60.0054,4603,267,6000Apr 01, 2021, 07:55 PM
BELOFF GREGGSee RemarksApr 01, 2021 Option Exercise$60.0013,196791,7600Apr 01, 2021, 07:53 PM
Kakkar RahulChief Executive OfficerApr 01, 2021 Option Exercise$60.0014,000840,0000Apr 01, 2021, 07:50 PM
Kakkar RahulChief Executive OfficerApr 01, 2021 Option Exercise$60.00702,51542,150,9000Apr 01, 2021, 07:50 PM
Fuglesang ChristopherDirectorApr 01, 2021 Option Exercise$60.002,131,135127,868,1000Apr 01, 2021, 07:49 PM
Becker Daniel J.DirectorApr 01, 2021 Option Exercise$60.002,827,883169,672,9800Apr 01, 2021, 07:49 PM
Becker Daniel J.DirectorApr 01, 2021 Option Exercise$60.001,00060,0000Apr 01, 2021, 07:49 PM
Sundy JohnChief Medical OfficerApr 01, 2021 Option Exercise$60.00115,8266,949,5600Apr 01, 2021, 07:46 PM
Stagliano NancyDirectorApr 01, 2021 Option Exercise$60.0073,0674,384,0200Apr 01, 2021, 07:46 PM
Stagliano NancyDirectorApr 01, 2021 Option Exercise$60.001,00060,0000Apr 01, 2021, 07:46 PM
Frail DonaldDirectorApr 01, 2021 Option Exercise$60.0061,1133,666,7800Apr 01, 2021, 07:45 PM
Carroll JillDirectorApr 01, 2021 Option Exercise$60.005,674,221340,453,2600Apr 01, 2021, 07:43 PM
Larson Eric DVice President, FinanceApr 01, 2021 Option Exercise$60.0022,1251,327,5000Apr 01, 2021, 07:37 PM
Becker Daniel J.DirectorNov 19, 2020 Buy$15.12197,7162,989,4662,827,883Nov 23, 2020, 05:30 PM
Becker Daniel J.DirectorNov 18, 2020 Buy$15.2614,197216,6462,630,167Nov 19, 2020, 08:15 PM
Becker Daniel J.DirectorNov 17, 2020 Buy$15.3215,197232,7542,615,970Nov 19, 2020, 08:15 PM
ROCHE HOLDING LTD10% OwnerJul 21, 2020 Buy$18.0036,111649,9983,086,084Jul 23, 2020, 04:50 PM
Mutz MitchellDirectorJul 21, 2020 Buy$18.0010,000180,00010,000Jul 23, 2020, 04:49 PM
Mutz MitchellDirectorJul 21, 2020 Buy$18.0036,111649,9983,086,084Jul 23, 2020, 04:49 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerJul 21, 2020 Buy$18.00361,1116,499,9981,770,023Jul 22, 2020, 04:30 PM
GLAXOSMITHKLINE PLCDirectorJul 21, 2020 Buy$18.00361,1116,499,9982,248,304Jul 22, 2020, 04:18 PM
Polaris Partners GP VIII, L.L.C.10% OwnerJul 21, 2020 Buy$18.0036,111649,9983,090,801Jul 21, 2020, 07:51 PM
Boxer Capital, LLC10% OwnerJul 21, 2020 Buy$18.00722,22212,999,9962,107,513Jul 21, 2020, 07:49 PM
Carroll JillDirectorJul 21, 2020 Buy$18.00361,1116,499,9982,248,304Jul 21, 2020, 07:47 PM
Crane Alan LDirectorJul 21, 2020 Buy$18.0014,000252,00084,158Jul 21, 2020, 07:44 PM
Crane Alan LDirectorJul 21, 2020 Buy$18.0036,111649,9983,090,801Jul 21, 2020, 07:44 PM
Fuglesang ChristopherDirectorJul 21, 2020 Buy$18.00722,22212,999,9962,600,773Jul 21, 2020, 07:44 PM
Becker Daniel J.DirectorJul 21, 2020 Buy$18.001,00018,0001,000Jul 21, 2020, 07:39 PM
Becker Daniel J.DirectorJul 21, 2020 Buy$18.00722,22212,999,9962,600,773Jul 21, 2020, 07:39 PM
Goyal VikasSee RemarksJul 21, 2020 Buy$18.001,45026,10087,764Jul 21, 2020, 07:39 PM
Kakkar RahulChief Executive OfficerJul 21, 2020 Buy$18.0014,000252,00014,000Jul 21, 2020, 07:35 PM
Sundy JohnChief Medical OfficerJul 21, 2020 Buy$18.002,00036,000115,826Jul 21, 2020, 07:33 PM
Stagliano NancyDirectorJul 21, 2020 Buy$18.001,00018,0001,000Jul 21, 2020, 07:33 PM
Viney Joanne L.See RemarksJul 21, 2020 Buy$18.001,20021,6001,200Jul 21, 2020, 07:32 PM
Frail DonaldDirectorJul 21, 2020 Buy$18.0010,000180,00061,113Jul 21, 2020, 07:29 PM
Larson Eric DVice President, FinanceJul 21, 2020 Buy$18.0060010,80022,125Jul 21, 2020, 07:28 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Viney Joanne L.See Remarks04/01/202172,000
Viney Joanne L.See Remarks04/01/202130,195,240
Goyal VikasSee Remarks04/01/20215,265,840
Crane Alan LDirector04/01/20215,049,480
Crane Alan LDirector04/01/2021192,085,320
Crane Alan LDirector04/01/202120,178,840
Freedman Edward D.Chief Operating Officer04/01/20213,267,600
BELOFF GREGGSee Remarks04/01/2021791,760
Kakkar RahulChief Executive Officer04/01/2021840,000
Kakkar RahulChief Executive Officer04/01/202142,150,900
Fuglesang ChristopherDirector04/01/2021127,868,100
Becker Daniel J.Director04/01/2021169,672,980
Becker Daniel J.Director04/01/202160,000
Sundy JohnChief Medical Officer04/01/20216,949,560
Stagliano NancyDirector04/01/20214,384,020
Stagliano NancyDirector04/01/202160,000
Frail DonaldDirector04/01/20213,666,780
Carroll JillDirector04/01/2021340,453,260
Larson Eric DVice President, Finance04/01/20211,327,500
Becker Daniel J.Director11/19/20202,989,466
Becker Daniel J.Director11/18/2020216,646
Becker Daniel J.Director11/17/2020232,754
ROCHE HOLDING LTD10% Owner07/21/2020649,998
Mutz MitchellDirector07/21/2020180,000
Mutz MitchellDirector07/21/2020649,998
RA CAPITAL MANAGEMENT, L.P.10% Owner07/21/20206,499,998
GLAXOSMITHKLINE PLCDirector07/21/20206,499,998
Polaris Partners GP VIII, L.L.C.10% Owner07/21/2020649,998
Boxer Capital, LLC10% Owner07/21/202012,999,996
Carroll JillDirector07/21/20206,499,998
Crane Alan LDirector07/21/2020252,000
Crane Alan LDirector07/21/2020649,998
Fuglesang ChristopherDirector07/21/202012,999,996
Becker Daniel J.Director07/21/202018,000
Becker Daniel J.Director07/21/202012,999,996
Goyal VikasSee Remarks07/21/202026,100
Kakkar RahulChief Executive Officer07/21/2020252,000
Sundy JohnChief Medical Officer07/21/202036,000
Stagliano NancyDirector07/21/202018,000
Viney Joanne L.See Remarks07/21/202021,600
Frail DonaldDirector07/21/2020180,000
Larson Eric DVice President, Finance07/21/202010,800
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR PANDION THERAPEUTICS INC
LOADING...